NAD+ booster dosage in clinical studies
Pro Research Analysisby 
Searched over 200M research papers
NAD+ Booster Dosage in Clinical Studies: Key Findings
Nicotinamide Riboside (NR) and NR Combinations Dosage
Clinical studies have tested nicotinamide riboside (NR) at various dosages. In a randomized, double-blind, placebo-controlled trial, healthy adults aged 60–80 took either a recommended dose (NRPT 1X) or double dose (NRPT 2X) of a combination of NR and pterostilbene (NRPT) daily for eight weeks. The NRPT 1X group saw about a 40% increase in NAD+ levels, while the NRPT 2X group saw about a 90% increase after four weeks, with these increases sustained for the full eight weeks. The study confirmed a dose-dependent effect and reported no serious adverse events, supporting the safety of both dosages over this period .
Another study evaluated a single 500 mg oral dose of NR and found it was safe and increased NAD+ levels, but intravenous (IV) NR at 500 mg produced a more robust and rapid increase in NAD+ compared to oral NR or NAD+ IV, with no significant adverse events reported .
Niacin (Vitamin B3) Dosage
In patients with adult-onset mitochondrial myopathy, niacin (vitamin B3) was administered at increasing doses up to 750–1,000 mg per day for 4–10 months. This regimen led to up to an 8-fold increase in blood NAD+ and improved muscle NAD+ to levels seen in healthy controls. The study noted some patients developed a tendency toward anemia, but overall, muscle strength and mitochondrial biogenesis improved .
Nicotinamide (NAM) Dosage
A study using a single oral dose of nicotinamide at 200 mg (the daily tolerable upper level) in healthy subjects showed a 17% increase in blood nicotinamide and a rise in NAD+ levels, peaking at 12 hours post-dose. The effects lasted up to 24 hours before returning to baseline, suggesting that repeated dosing within the safety range could be effective for sustained NAD+ elevation .
Nicotinamide Mononucleotide (NMN) Dosage
A post-hoc analysis of a double-blind clinical trial tested daily NMN supplementation at 300 mg, 600 mg, or 900 mg for 60 days in adults aged 40–65. All doses led to a dose-dependent increase in blood NAD+ concentration, but there was high variability between individuals. The study suggests that monitoring NAD+ levels may help tailor personalized NMN dosages for optimal benefit .
Combination Formulations
A pilot study tested a combination of nicotinamide and D-ribose (RiaGev) at 1,520 mg twice daily for 7 days in healthy middle-aged adults. This regimen significantly increased the NAD+ metabolome, especially NADP+, and improved markers of energy metabolism and stress, with no significant adverse events .
Acipimox Dosage
In a study involving patients with type 2 diabetes, acipimox (a nicotinic acid derivative) was given at 250 mg three times daily for two weeks. This regimen increased muscle mitochondrial function and NAD+ levels, demonstrating a direct effect on muscle metabolism .
Ex Vivo and In Vitro Dosage Insights
Studies using leukocytes from rheumatoid arthritis patients treated ex vivo with 1 mM concentrations of NAD+ boosters (including NR, NMN, and NAM) for 24 hours showed significant increases in NAD+ levels and reductions in oxidative stress, apoptosis, and inflammatory mediators Pérez-Sánchez2021Pérez-Sánchez2023. While these are not in vivo dosages, they provide insight into effective concentrations for cellular studies.
Safety and Uncertainties
Most clinical studies report that NAD+ boosters are safe at the tested dosages, with few adverse events. However, there are still uncertainties regarding the optimal dose, long-term safety, and individual variability in response. More research is needed to determine the best dosing strategies for different populations and conditions Poljšak2022Kuerec2024.
Conclusion
Clinical studies have tested a range of NAD+ booster dosages, including NR (250–500 mg daily or IV), niacin (up to 1,000 mg daily), NMN (300–900 mg daily), nicotinamide (200 mg single dose), and combination products (1,520 mg twice daily). All have shown the ability to increase NAD+ levels, often in a dose-dependent manner, with good safety profiles in the short term. However, individual responses vary, and more research is needed to optimize dosing for long-term use and specific health outcomes Dellinger2017Pirinen2020Hawkins2024+4 MORE.
Sources and full results
Most relevant research papers on this topic
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Repeat dose NRPT (nicotinamide riboside and pterostilbene) is a safe and effective way to increase NAD+ levels sustainably in healthy adults.
Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.
Niacin effectively boosts NAD+ levels and improves muscle strength and mitochondrial biogenesis in adult-onset mitochondrial myopathy patients, reducing anemia and liver fat.
Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen+ IV and NAD+ IV in healthy adults
Intravenous nicotinamide riboside (NRIV) is safe and well-tolerated for boosting blood NAD+ levels in healthy adults, with faster infusion times and better tolerability compared to NAD+ IV.
DOI